Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Final analysis from the NIVOREN GETUG AFU 26 study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreSafety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Final analysis from the NIVOREN GETUG AFU 26 study.
Type de publicationJournal Article
Year of Publication2019
AuteursAlbiges L, Negrier S, Dalban C, Chevreau C, Gravis G, Oudard S, Laguerre B, Barthelemy P, Borchiellini D, Gross-Goupil M, Geoffrois L, Rolland F, Thiery-Vuillemin A, Joly F, Ladoire S, Tantot F, Escudier B
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAR 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.7_suppl.542